Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patients

被引：12
|
作者：
Gruson, Damien [1 ,2 ,3 ]
Ferracin, Benjamin [2 ,3 ]
Ahn, Sylvie A. [4 ,5 ]
Rousseau, Michel F. [4 ,5 ]
机构：
[1] Clin Univ St Luc, Inst Rech Expt & Clin, Pole Rech Endocrinol Diabet & Nutr, B-1200 Brussels, Belgium
[2] Clin Univ St Luc, Dept Lab Med, B-1200 Brussels, Belgium
[3] Catholic Univ Louvain, B-1200 Brussels, Belgium
[4] Catholic Univ Louvain, Inst Rech Expt & Clin, Clin Univ St Luc, Div Cardiol, B-1200 Brussels, Belgium
[5] Catholic Univ Louvain, Inst Rech Expt & Clin, Div Cardiol, Pole Rech Cardiovasc, B-1200 Brussels, Belgium
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2015年 / 189卷
关键词：
FGF-23; Galectin-3; ST2; NT-proBNP; BNP; Biomarker; Heart failure; Prognosis; EXPRESSION; PREDICTOR;
D O I：
10.1016/j.ijcard.2015.04.074
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：185 / 187
页数：3
相关论文
共 50 条
  • [21] Serial soluble ST2 and galectin-3 measurement and its association with LV systolic and diastolic function in chronic heart failure patients after acute decompensation
    Protasov, V. Vladimir
    Skvortsov, A.
    Koshkina, D.
    Narusov, O.
    Masenko, V.
    Tereschenko, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 102 - 102
  • [22] SuPAR, Galectin-3 and ST2 Are Associated With Chronic Kidney Disease Progression in Patients With Heart Failure With Reduced Ejection Fraction
    Gordon, Jonathan S.
    Roehm, Bethany
    Xu, Pin
    McAdams, Meredith
    Grodin, Justin L.
    Hedayati, Susan
    CIRCULATION, 2022, 146
  • [23] The emerging role of galectin-3 and ST2 in heart failure: Practical considerations and pitfalls using novel biomarkers
    Karayannis G.
    Triposkiadis F.
    Skoularigis J.
    Georgoulias P.
    Butler J.
    Giamouzis G.
    Current Heart Failure Reports, 2013, 10 (4) : 441 - 449
  • [24] Exploring the Causal Effects of Circulating ST2 and Galectin-3 on Heart Failure Risk: A Mendelian Randomization Study
    Wang, Xizhi
    Wang, Xingchen
    Zhu, Jun
    Liu, Yu
    Zhuang, Lenan
    Zhang, Zhe
    Zhong, Danfeng
    Zhang, Wenbin
    Lai, Dongwu
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [25] Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community-Dwelling Population
    Parikh, Ravi H.
    Seliger, Stephen L.
    Christenson, Robert
    Gottdiener, John S.
    Psaty, Bruce M.
    deFilippi, Christopher R.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (08):
  • [26] The role of soluble st2 and galectin-3 in hypertrophic cardiomyopathy assessed by cardiac magnetic resonance
    Spiewak, M.
    Marczak, M.
    Kozuch, K.
    Janas, J.
    Grzybowski, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 565 - 565
  • [27] The ratio of fibroblast growth factor 23 to phosphorus as a predictor of cardiovascular death in heart failure patients with reduced ejection fraction.
    Gruson, D. Damien
    Ahn, S. A.
    Carbone, V.
    Rousseau, M. F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 221 - 221
  • [28] Interleukin 6, galectin 3, growth differentiation factor 15, and soluble ST2 for mortality prediction in critically ill patients
    Dieplinger, Benjamin
    Egger, Margot
    Leitner, Isabella
    Firlinger, Fritz
    Poelz, Werner
    Lenz, Kurt
    Haltmayer, Meinhard
    Mueller, Thomas
    JOURNAL OF CRITICAL CARE, 2016, 34 : 38 - 45
  • [29] ST2 and galectin-3 as novel biomarkers for the prediction of future cardiovascular disease risk in preeclampsia
    Atakul, Nil
    Atamer, Yildiz
    Selek, Sahabettin
    Kilic, Berna
    Koktasoglu, Fatmanur
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (05) : 1023 - 1029
  • [30] The soluble ST2 levels in patients with depression and comorbid heart failure
    Sikora, A.
    Fedorov, S.
    Vynnyk, M.
    Pustovoyt, M.
    Pityk, O.
    Bezuk, J.
    EUROPEAN PSYCHIATRY, 2022, 65 : S111 - S112
12345